Form 483

BHP Holdings Inc Form 483, 2016-09-30

FDA issued a Form 483 to BHP Holdings Inc on 2016-09-30 with 14 public-safe observations.

483· Form 483 issuedFoods & Cosmetics14 observations

BHP Holdings Inc · Woodinville, United States · Issued September 30, 2016

Overview

  • 14 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Sep 2016
21 CFR 111.103

Written procedures - quality control operations

Cited by Andrew K Haack, Jinkee M Vila Binayug

30 Sep 2016
21 CFR 111.103

Written procedures - quality control operations

Cited by Andrew K Haack, Jinkee M Vila Binayug

30 Sep 2016
21 CFR 111.153

Written procedures - components

Cited by Andrew K Haack, Jinkee M Vila Binayug

30 Sep 2016
21 CFR 111.153

Written procedures - components

Cited by Andrew K Haack, Jinkee M Vila Binayug

30 Sep 2016
21 CFR 111.255(a)

Batch record - every batch

Cited by Andrew K Haack, Jinkee M Vila Binayug

Inspected site

BHBHP Holdings IncWoodinville, United States

Inspection team

JMJinkee M Vila Binayug

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.103Cited across public-safe Form 483 observations2x
21 CFR 111.153Cited across public-safe Form 483 observations2x
21 CFR 111.255(a)Cited across public-safe Form 483 observations2x
21 CFR 111.403Cited across public-safe Form 483 observations2x
21 CFR 111.453Cited across public-safe Form 483 observations2x
21 CFR 111.570(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.75(e)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 14 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere